Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |